Program

The event is split up into 3 parts – a scientific symposium with renowned speakers from all over the world, an international best-practices panel, and a celebration and fundraising event in the evening.


Part I: Health Policy and Quality Improvement

Session 1

 

Opening Session

Moderated by:
Konrad Reinhart
Sepsis Stiftung, Germany

11:00h Berlin Time (CEST)

Welcome Remarks
Niranjan ‘Tex’ Kissoon, President Global Sepsis Alliance, Canada
Konrad Reinhart, Chair Sepsis Stiftung, Germany

Greetings

The WHO Strategy to Fight Infection-Related Global Health Threats
Zsuzsanna Jakab, Deputy Director‐General World Health Organization, Switzerland

A Husband and Father’s Perspective on Sepsis
Joachim Greuner, Germany

A Sepsis Survivor’s Perspective on Sepsis
Dennis Kredler, European Sepsis Alliance, Belgium

Keynote: Sepsis in the Context of Patient Safety
Ciarán Staunton, End Sepsis – The Legacy of Rory Staunton, USA


Session 2

 

The Burden of Sepsis, COVID-19, and AMR

Moderated by:
Edmund Neugebauer
Brandenburg Medical School, Germany
Emmanuel Nsutebu
African Sepsis Alliance, United Arab Emirates

12:05h Berlin Time (CEST)

The Global Burden of Sepsis and AMR
Mohsen Naghavi, Institute for Health Metrics and Evaluation, USA

Addressing the Burden of Sepsis in Children Under Five
Niranjan ‘Tex’ Kissoon, Global Sepsis Alliance, Canada

The Burden of Sepsis and COVID-19 in Germany
Carolin Fleischmann‐Struzek, Jena University Hospital, Germany

Sepsis Knowledge – Results from a Representative Survey
Roman Marek, Sepsis Stiftung, Germany


Lunch Break


Session 3

 

Panel: How to Boost the Implementation of the WHA Sepsis Resolution

Moderated by:
Abdulelah Alhawsawi
Global Sepsis Alliance, Saudi Arabia
Ron Daniels
Global Sepsis Alliance, UK

13:30h Berlin Time (CEST)

Synergies between Pandemic Preparedness, IPC, Sepsis, and AMR
Hanan Balkhy, Assistant Director‐General, World Health Organization, Switzerland

Why Sepsis Needs to Be in the Public and Political Space
Keith Martin, Consortium of Universities for Global Health, USA

The Strategy of WHO Europe in the Fight Against Sepsis
João Breda, Special Adviser at WHO Regional Office for Europe, Greece

Lessons from the Pandemic to Fight Non-COVID Sepsis
Janet Diaz, World Health Organization, Switzerland

WHO HQ Efforts to Improve the Evidence‐Based Management of Sepsis
Teri Reynolds, World Health Organization, Switzerland

Discussion by the panelists


Session 4

 

Learning by Exchange on the Global, National, and Facility Level

Moderated by:
Bjoern Weiss
Charité University Hospital, Germany
Imrana Malik
Global Sepsis Alliance, USA

14:25h Berlin Time (CEST)

Challenges in Addressing Sepsis in Sub-Saharan Africa
Shevin Jacob, African Sepsis Alliance, Uganda

Australia’s National Action Plan to Fight Sepsis, COVID-19, and AMR
Brett Abbenbroek, Asia Pacific Sepsis Alliance, Australia

Impact of Sepsis Mandates on Patient Outcomes
Marcus Friedrich, BIH/Charité Visiting Professor, USA

Using Synergies to Fight Pandemics, Sepsis, and AMR
Ron Daniels, European Sepsis Alliance, United Kingdom

Lessons Learned by the German Quality Network Sepsis
Daniel Schwarzkopf, Jena University Hospital, Germany

Q&A


Coffee Break


Session 5

 

Panel: The Challenges of, and Lessons Learned from the Pandemic

Moderated by:
Volkart Wildermuth
Science Journalist, Germany

15:55h Berlin Time (CEST)

Placing Sepsis Prevention and Control Into the WHO Global Context
Rudi Eggers, Director Integrated Health Services, World Health Organization, Switzerland

The Perspective of a Dean and Scientist
Axel Pries, Charité University Hospital, Germany

The Perspective of a Science Editor
Joachim Mueller‐Jung, Frankfurter Allgemeine Zeitung, Germany

The Perspective of a Vaccine Researcher and Developer
Stefan Kaufmann, Max Planck Institute, Germany

The Perspective from Africa and the Eastern Mediterranean Region
Emmanuel Nsutebu, Chair African Sepsis Alliance, United Arab Emirates

Novel Immunomodulatory and Biomarker Approaches in COVID-19 and Sepsis
Evangelos J. Giamarellos‐Bourboulis, Chair European Sepsis Alliance, Greece

On the Importance of and the Barriers to Clinical Research
Tobias Welte, Sepsis Stiftung, Germany

For Evaluating Novel Therapeutics – The Perspective of a Biotech CEO
Niels Riedemann, InflaRx, Germany

Discussion by the panelists


Part II: Panel – Learning from Successful National Sepsis Initiatives


Panel: Learning from Successful National Sepsis Initiatives

Moderated by:
Edmund Neugebauer
Brandenburg Medical School, Germany
Daniel Schwarzkopf
Jena University Hospital, Germany

18:00h Berlin Time (CEST)

The Success Factors of the Surviving Sepsis Campaign on a Global Scale
Mitchell Levy, Brown University, USA

The Challenges and Successes in the Fight Against Sepsis in Latin America
Daniela Carla Souza, Sírio-Libanês Hospital, Brazil

Building a Successful National Sepsis Campaign in Japan
Naoyuki Matsuda, Japanese Sepsis Alliance, Japan

The History and Success Factors for the Sudanese National Sepsis Plan
Mohammed Elfatih Ahmed, Sudanese Sepsis Alliance, Sudan

Background and Impact of the National Clinical Programme on Sepsis Mortality
Michael O‘Dwyer, Health Service Executive, Ireland

History, Achievements, and Future Strategy by Sepsis Alliance in the US
Thomas Heymann, Sepsis Alliance, USA

The Role of Nurses in the National Sepsis QI Initiative in Saudi Arabia
Maha Aljuaid, Global Sepsis Alliance, Saudi Arabia

The Strategy of the MoH-Funded “Germany Recognizes Sepsis”-Coalition
Ellen Heyd, Coalition for Patient Safety, Germany

The SepWiss Project in Berlin and Brandenburg: Strategy and Lessons Learned
Wiltrud Abels, Sepsis Stiftung, Germany

Discussion by the panelists


Part III: Celebration and Fundraising Event

The program for the evening event is available here.